Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
Nina Friis‐Møller(University of Copenhagen), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Wafaa El‐Sadr(Columbia University Irving Medical Center), Rodolphe Thiébaut(Université de Bordeaux), Ole Kirk(University of Copenhagen), Linda Morfeldt(Hvidovre Hospital), Christian Pradier(Université Côte d'Azur), Rainer Weber(Georg Simon Ohm University of Applied Sciences Nuremberg), Antonella d’Arminio Monforte(University of Milan), Matthew Law(UNSW Sydney), Caroline Sabin(Primary Health Care), Stephan De Wit, Peter Reiss(Amsterdam Institute for Global Health and Development), Silvia Mateu, Andrew Phillips(Wake Forest University)
Cited by 327
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k